Pubblicazioni

PKCÎ»/Î¹ inhibition activates an ULK2-mediated interferon response to repress tumorigenesis

2021 - MOLECULAR CELL

Linares, J. F.; Zhang, X.; Martinez-Ordonez, A.; Duran, A.; Kinoshita, H.; Kasashima, H.; Nakanishi, N.; Nakanishi, Y.; Carelli, R.; Cappelli, L.; Arias, E.; Yashiro, M.; Ohira, M.; Patel, S.; Inghirami, G.; Loda, M.; Cuervo, A. M.; Diaz-Meco, M. T.; Moscat, J.

Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy â A multicentre study of 90 patients from the German Dermatooncology Group

2021 - EUROPEAN JOURNAL OF CANCER

Grimmelmann, I.; Momma, M.; Zimmer, L.; Hassel, J. C.; Heinzerling, L.; Pfohler, C.; Loquai, C.; Ruini, C.; Utikal, J.; Thoms, K. -M.; Kahler, K. C.; Eigentler, T.; Herbst, R. A.; Meier, F.; Debus, D.; Berking, C.; Kochanek, C.; Ugurel, S.; Gutzmer, R.

Impact of glycemic variability on chromatin remodeling, oxidative stress, and endothelial dysfunction in patients with type 2 diabetes and with target HbA1c levels

2017 - DIABETES

Costantino, Sarah; Paneni, Francesco; Battista, Rodolfo; Castello, Lorenzo; Capretti, Giuliana; Chiandotto, Sergio; Tanese, Luigi; Russo, Giulio; Pitocco, Dario; Lanza, Gaetano A.; Volpe, Massimo; LÃ¼scher, Thomas F.; Cosentino, Francesco

Pubblicazioni

PKCÎ»/Î¹ inhibition activates an ULK2-mediated interferon response to repress tumorigenesis

Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy â A multicentre study of 90 patients from the German Dermatooncology Group

Impact of glycemic variability on chromatin remodeling, oxidative stress, and endothelial dysfunction in patients with type 2 diabetes and with target HbA1c levels

Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy â A multicentre study of 90 patients from the German Dermatooncology Group